[Bevacizumab (Avastin) related surgical complications: comment to Abbrederis K et al. (2007)]

Autor: F, Lordick, J R, Siewert

Publikováno v: Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen. 79(4)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2b3e0256e4ab47e033f7d02654692584
https://pubmed.ncbi.nlm.nih.gov/17453167

Disclosing the CXCR4 expression status in multiple myeloma by in vivo molecular imaging

Autor: Herrmann, Ken, Philipp-Abbrederis, K., Schottelius, M., Eiber, M., Lapa, Constantin, Beer, A., Knop, S., Rudelius, M., Gerngross, C., Götze, K., Einsele, H., Buck, A., Schwaiger, M., Wester, H., Keller, U.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3341::4d4fefcb888413c5d987d63f48d72a35
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/63767

Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies.

Autor: Petzer V; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria., Steiner N; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria., Angelova-Unterberger O; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria., Hetzenauer G; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria., Philipp-Abbrederis K; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria., Willenbacher E; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria., Feistritzer C; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria., Willenbacher W; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria., Rudzki J; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria., Stauder R; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria., Kocher F; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria., Seeber A; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria., Pircher A; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria., Tymoszuk P; Data Analytics As a Service Tirol, DAAS Tirol, Innsbruck, Austria., Isara C; Central Institute of Clinical Chemistry and Laboratory Medicine Medical University of Innsbruck, Austria., Egger A; Central Institute of Clinical Chemistry and Laboratory Medicine Medical University of Innsbruck, Austria., Fux V; Central Institute of Clinical Chemistry and Laboratory Medicine Medical University of Innsbruck, Austria., Anliker M; Central Institute of Clinical Chemistry and Laboratory Medicine Medical University of Innsbruck, Austria., Gunsilius E; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria., Nachbaur D; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria., Schmidt S; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria., Wolf D; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria.

Publikováno v: HemaSphere [Hemasphere] 2022 Feb 15; Vol. 6 (3), pp. e686. Date of Electronic Publication: 2022 Feb 15 (Print Publication: 2022).

Clinical Effectiveness of Minimal and Atoxic Doses of Interferon Alpha for Treatment of Hairy Cell Leukemia1

Autor: H. Rokos, Herbert Tilg, C.-H. Nerl, Jakob Troppmair, Abbrederis K, Günther Gastl, C. Huber, R. Flener, W. Aulitzky

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8a1948ede05f28da4e445214b6226bf9
https://doi.org/10.1159/000413699

Comparison of nab-paclitaxel plus gemcitabine in elderly versus younger patients with metastatic pancreatic cancer: Analysis of a multicentre, prospective, non-interventional study.

Autor: Prager GW; Medical University of Vienna, Department of Oncology, Währinger Gürtel 18-20, 1090, Vienna, Austria. Electronic address: gerald.prager@meduniwien.ac.at., Oehler L; Sankt Josef Krankenhaus, Internal Medicine 2, Auhofstraße 189, 1130, Vienna, Wien, Austria. Electronic address: leopold.oehler@sjk-wien.at., Gerger A; Medical University of Graz, Clinical Institute of Oncology, Auenbruggerplatz 15, 8036, Graz, Austria. Electronic address: armin.gerger@klinikum-graz.at., Mlineritsch B; Universitätsklinik Salzburg, University Clinic for Internal Medicine III, Müllner Haupstraße 48, 5020, Salzburg, Austria. Electronic address: brigitte@mlineritsch.com., Andel J; Pyhrn-Eisenwurzen Klinikum, Internal Medicine II, Sierningerstraße 170, 4400, Steyr, Austria. Electronic address: johannes.andel@ooeg.at., Petzer A; Ordensklinikum Linz BHS - EKH, Internal Medicine I, Medical Oncology and Hematology, Seilerstätte 4, 4010, Linz Austria. Electronic address: andreas.petzer@ordensklinikum.at., Wilthoner K; Landeskrankenhaus Vöcklabruck, Vöcklabruck, Internal Medicine, Hemato-Oncology, Dr. Wilhelm-Bock-Straße 1, 4840 Vöcklabruck, Austria. Electronic address: Klaus.Wilthoner@ooeg.at., Sliwa T; Hanuschkrankenhaus, Medicine III for Hematology and Oncology, Heinrich-Collin-Straße 30, 1140, Wien, Vienna, Austria. Electronic address: thamer.sliwa@gmail.com., Pichler P; Universitätsklinikum St. Pölten, Internal Medicine I, Dunant-Platz 1, 3100, Sankt Pölten, Austria. Electronic address: petra.pichler@stpoelten.lknoe.at., Winder T; Landeskrankenhaus Feldkirch, Internal Medicine II, Carinagasse 47, 6807, Feldkirch, Austria. Electronic address: Thomas.Winder@vlkh.net., Heibl S; Klinikum Wels-Grieskirchen, Internal Medicine IV, Grieskirchner Straße 42, 4600, Wels, Austria. Electronic address: sonja.heibl@klinikum-wegr.at., Gruenberger B; Landesklinikum Wiener Neustadt, Internal Medicine for Hematology and Internal Oncology, Corvinusring 2-5, 2700, Wiener Neustadt, Austria. Electronic address: Birgit.Gruenberger@wienerneustadt.lknoe.at., Laengle F; Landesklinikum Wiener Neustadt, Department of Surgery, Corvinusring 2-5, 2700, Wiener Neustadt, Austria. Electronic address: friedrich.laengle@wienerneustadt.lknoe.at., Hubmann E; Krankenhaus der Barmherzigen Brüder, Internal Medicine, Marschallgasse 12, 8020, Graz, Austria. Electronic address: eva.hubmann@bbgraz.at., Korger M; Krankenhaus der Barmherzigen Brüder, Internal Medicine II, Johannes von Gott-Platz 1, 7000, Eisenstadt, Austria. Electronic address: markus.korger@bbeisen.at., Pecherstorfer M; Karl Landsteiner University of Health Sciences, Department of Internal Medicine, University Hospital, 3500, Krems an der Donau, Austria. Electronic address: martin.pecherstorfer@krems.lknoe.at., Djanani A; Medical University of Innsbruck, Institute of Gastroenterology, Internal Medicine I, Institute of Gastroenterology, Anichstraße 35, 6020, Innsbruck, Austria. Electronic address: angela.djanani@tirol-kliniken.at., Neumann HJ; Krankenhaus der Elisabethinen, Internal Medicine, Völkermarkter Straße 15-19, 9020, Klagenfurt, Austria. Electronic address: hansjoerg.neumann@ekh.at., Philipp-Abbrederis K; Medical University of Innsbruck, Institute of Hematology and Oncology, Internal Medicine V, Institute of Hematology and Oncology, Anichstraße 35, 6020, Innsbruck, Austria. Electronic address: kathrin.philipp-abbrederis@tirol-kliniken.at., Wöll E; Krankenhaus Zams, Internal Medicine, Sanatoriumstraße 43, 6511, Zams, Austria. Electronic address: ewald.woell@krankenhaus-zams.at., Trondl R; Celgene Austria GmbH, EuroPlaza Building E, Technologiestraße 10, 1120, Vienna, Austria. Electronic address: robert.trondl@bms.com., Arnold-Schrauf C; Celgene Austria GmbH, EuroPlaza Building E, Technologiestraße 10, 1120, Vienna, Austria. Electronic address: catharina.arnold-schrauf@bms.com., Eisterer W; Klinikum Klagenfurt Am Wörthersee, Internal Medicine and Oncology, Feschnigstraße 11, 9020, Klagenfurt, Austria. Electronic address: wolfgang.eisterer@kabeg.at.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Jan; Vol. 143, pp. 101-112. Date of Electronic Publication: 2020 Dec 06.